The safety and efficacy of "bloodless" cardiac surgery

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 9, Issue 1, 2005, Pages 53-63

  Shander, Aryeh ^a   Moskowitz, David ^a   Rijhwani, Tanuja S ^a  

^a ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; APROTININ; CYANOCOBALAMIN; DESMOPRESSIN; FIBRINOGEN; FOLIC ACID; GELFOAM; HEMOGLOBIN; HEPARIN; IRON; MICROCRYSTALLINE COLLAGEN; OXIDIZED REGENERATED CELLULOSE; OXYGEN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTERIAL OXYGEN TENSION; BACTERIUM CONTAMINATION; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD CLOTTING DISORDER; BLOOD STORAGE; BLOOD TRANSFUSION; BODY TEMPERATURE; DIURESIS; HEART SURGERY; HEMODILUTION; HEMOFILTRATION; HEMOLYSIS; HUMAN; HYPERTENSION; HYPERVENTILATION; LUNG INJURY; METABOLIC ALKALOSIS; OXYGEN AFFINITY; OXYGEN TRANSPORT; PARTIAL THROMBOPLASTIN TIME; PHLEBOTOMY; PROTHROMBIN TIME; REVIEW; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY; VIRUS INFECTION; VITAMIN SUPPLEMENTATION;

BLOOD PRESERVATION; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; HUMANS;

EID: 14744274233     PISSN: 10892532     EISSN: None     Source Type: Journal    
DOI: 10.1177/108925320500900106     Document Type: Review

References (107)

1. Goodnough LT, Johnston MF, Toy PT: The variability of transfusion practice in coronary artery bypass surgery. Transfusion Medicine Academic Award Group. JAMA 265:86-90, 1991.
2. Stover EP, Siegel LC, Parks R, et al: Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: A 24-institution study. Institutions of the Multicenter Study of Perioperative Ischemia Research Group. Anesthesiology 88:327-333, 1998.
3. Moskowitz DM, Klein JJ, Shander A, et al: Predictors of transfusion requirements for cardiac surgical procedures at a blood conservation center. Ann Thorac Surg 77:626-634, 2004.
4. Blumberg N: Allogeneic transfusion and infection: Economic and clinical implications. Semin Hematol 34:34-40, 1997.
5. Wu WC, Rathore SS, Wang Y, et al: Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345:1230-1236, 2001.
6. Engoren MC, Habib RH, Zacharias A, et al: Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 74:1180-1186, 2002.
7. Leal-Noval SR, Rincon-Ferrari MD, Garcia-Curiel A, et al: Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 119:1461-1468, 2001.
8. Chelemer SB, Prato BS, Cox PM, Jr., et al: Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. Ann Thorac Surg 73:138-142, 2002.
9. Helm RE, Rosengart TK, Gomez M, et al: Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion. Ann Thorac Surg 65:125-136, 1998.
10. Shander A: Emerging risks and outcomes of blood transfusion in surgery. Semin Hematol 41:117-124, 2004.
11. Brown P: Transfusion medicine and spongiform encephalopathy. Transfusion 41:433-436, 2001.
12. Palavecino E, Yomtovian R: Risk and prevention of transfusion-related sepsis. Curr Opin Hematol 10:434-439, 2003.
13. Thurer RL: Blood transfusion in cardiac surgery. Can J Anaesth 48:S6-12, 2001.
14. Williamson LM, Lowe S, Love EM, et al: Serious hazards of transfusion (SHOT) initiative: Analysis of the first two annual reports. Bmj 319:16-19, 1999.
15. Krombach J, Kampe S, Gathof BS, et al: Human error: The persisting risk of blood transfusion: A report of five cases. Anesth Analg 94:154-156, table of contents, 2002.
16. Vamvakas EC, Blajchman MA: Deleterious clinical effects of transfusion-associated immunomodulation: Fact or fiction? Blood 97:1180-1195, 2001.
17. Vamvakas EC, Carven JH: Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: Effect of the length of storage of transfused red cells. Transfusion 39:701-710, 1999.
18. Fransen E, Maessen J, Dentener M, et al: Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 116:1233-1239, 1999.
19. Murphy PJ, Connery C, Hicks GL, Jr., et al: Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft operations. J Thorac Cardiovasc Surg 104:1092-1099, 1992.
20. Gol MK, Karahan M, Ulus AT, et al: Bloodstream, respiratory, and deep surgical wound infections after open heart surgery. J Card Surg 13:252-259, 1998.
21. Norfolk DR, Williamson LM: Leucodepletion of blood products by filtration. Blood Rev 9:7-14, 1995.
22. Dzik WH, Corwin H, Goodnough LT, et al: Patient safety and blood transfusion: New solutions. Transfus Med Rev 17:169-180, 2003.
23. Helm RE, Gold JP, Rosengart TK, et al: Erythropoietin in cardiac surgery. J Card Surg 8:579-606, 1993.
24. Laupacis A, Fergusson D: Erythropoietin to minimize perioperative blood transfusion: A systematic review of randomized trials. The International Study of Peri- operative Transfusion (ISPOT) Investigators. Transfus Med 8:309-317, 1998.
25. Sowade O, Warnke H, Scigalla P, et al: Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery. Blood 89:411-418, 1997.
26. Yazicioglu L, Eryilmaz S, Sirlak M, et al: Recombinant human erythropoietin administration in cardiac surgery. J Thorac Cardiovasc Surg 122:741-745, 2001.
27. D'Ambra MN, Gray RJ, Hillman R, et al: Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients. Ann Thorac Surg 64:1686-1693, 1997.
28. Sowade B, Sowade O, Mocks J, et al: The safety of treatment with recombinant human erythropoietin in clinical use: A review of controlled studies. Int J Mol Med 1:303-314, 1998.
29. Lincoff AM, LeNarz LA, Despotis GJ, et al: Abciximab and bleeding during coronary surgery: Results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing. Ann Thorac Surg 70:516-526, 2000.
30. Reich DL, Patel GC, Vela-Cantos F, et al: Aspirin does not increase homologous blood requirements in elective coronary bypass surgery. Anesth Analg 79:4-8, 1994.
31. Bashein G, Nessly ML, Rice AL, et al: Preoperative aspirin therapy and reoperation for bleeding after coronary artery bypass surgery. Arch Intern Med 151:89-93, 1991.
32. Gammie JS, Zenati M, Kormos RL, et al: Abciximab and excessive bleeding in patients undergoing emergency cardiac operations. Ann Thorac Surg 65:465-469, 1998.
33. Sethi GK, Copeland JG, Goldman S, et al: Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy. J Am Coll Cardiol 15:15-20, 1990.
34. Hongo RH, Ley J, Dick SE, et al: The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol 40:231-237, 2002.
35. Dzik WH, Fleisher AG, Ciavarella D, et al: Safety and efficacy of autologous blood donation before elective aortic valve operation. Ann Thorac Surg 54:1177-1180; discussion 1180-1181, 1992.
36. Owings DV, Kruskall MS, Thurer RL, et al: Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood use. JAMA 262:1963-1968, 1989.
37. Van Dyck MJ, Baele PL, Leclercq P, et al: Autologous blood donation before myocardial revascularizatibn: A Holter-electrocardiographic analysis. J Cardiothorac Vasc Anesth 8:162-167, 1994.
38. Goodnough LT, Monk TG: Evolving concepts in autologous blood procurement and transfusion: Case reports of perisurgical anemia complicated by myocardial infarction. Am J Med 101:335-375, 1996.
39. Etchason J, Petz L, Keeler E, et al: The cost effectiveness of preoperative autologous blood donations [see comments]. N Engl J Med 332:719-724, 1995.
40. Kiyama H, Ohshima N, Imazeki T, et al: Autologous blood donation with recombinant human erythropoietin in anemic patients. Ann Thorac Surg 68:1652-1656, 1999.
41. Gombotz H: Subcutaneous epoetin alfa as an adjunct to autologous blood donation before elective coronary artery bypass graft surgery. Semin Hematol 33:69-70; discussion 71-72, 1996.
42. Kochamba GS, Pfeffer TA, Sintek CF, et al: Intraoperative autotransfusion reduces blood loss after cardiopulmonary bypass. Ann Thorac Surg 61:900-903, 1996.
43. Whitten CW, Allison PM, Latson TW, et al: Evaluation of laboratory coagulation and lytic parameters resulting from autologous whole blood transfusion during primary aortocoronary artery bypass grafting. J Clin Anesth 8:229-235, 1996.
44. Schonberger JP, Bredee JJ, Tjian D, et al: Intraoperative predonation contributes to blood saving. Ann Thorac Surg 56:893-898, 1993.
45. Jovic MD, Calija BM, Radomir BJ, et al: The use of acute normovolemic hemodilution in patients undergoing cardiac surgery. Cardiovasc Surg 11:201-295, 2003.
46. Casati V, Speziali G, D'Alessandro C, et al: Intraoperative low-volume acute normovolemic hemodilution in adult open-heart surgery. Anesthesiology 97:367-233, 2002.
47. Hohn L, Schweizer A, Licker M, et al: Absence of beneficial effect of acute normovolemic hemodilution combined with aprotinin on allogeneic blood transfusion requirements in cardiac surgery. Anesthesiology 96:276-282, 2002.
48. Herregods L, Moerman A, Foubert L, et al: Limited intentional normovolemic hemodilution: ST-segment changes and use of homologous blood products in patients with left main coronary artery stenosis. J Cardiothorac Vasc Anesth 11:18-23, 1997.
49. Petry AF, Jost J, Sievers H: Reduction of homologous blood requirements by blood-pooling at the onset of cardiopulmonary bypass. J Thorac Cardiovasc Surg 107:1210-1214, 1994.
50. Weiskopf RB: Mathematical analysis of isovolemic hemodilution indicates that it can decrease the need for allogeneic blood transfusion. Transfusion 35:37-41, 1995.
51. Weiskopf RB: Efficacy of acute normovolemic hemodilution assessed as a function of fraction of blood volume lost. Anesthesiology 94:439-446, 2001.
52. Brecher ME, Rosenfeld M: Mathematical and computer modeling of acute normovolemic hemodilution. Transfusion 34:176-179, 1994.
53. Weiskopf RB, Viele MK, Feiner J, et al: Human cardiovascular and metabolic response to acute, severe isovolemic anemia [published erratum appears in JAMA 280(16):1404, 1998, see comments]. JAMA 279:217-221, 1998.
54. Hogue CW, Jr., Goodnough LT, Monk TG: Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion 38:924-931, 1998.
55. Hebert PC, Wells G, Blajchman MA, et al: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group [see comments] [published erratum appears in N Engl J Med 340:1056, 1999]. N Engl J Med 340:409-417, 1999.
56. Bracey AW, Radovancevic R, Riggs SA, et al: Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: Effect on patient outcome. Transfusion 39:1070-1077, 1999.
57. Johnson RG, Thurer RL, Kruskall MS, et al: Comparison of two transfusion strategies after elective operations for myocardial revascularization. J Thorac Cardiovasc Surg 104:307-314, 1992.
58. Most AS, Ruocco NA Jr, Gewirtz H: Effect of a reduction in blood viscosity on maximal myocardial oxygen delivery distal to a moderate coronary stenosis. Circulation 74:1085-1092, 1986.
59. Brazier J, Cooper N, Maloney JV Jr, et al: The adequacy of myocardial oxygen delivery in acute normovolemic anemia. Surgery 75:508-516, 1974.
60. van Woerkens EC, Trouwborst A, Duncker DJ, et al: Regional cardiac hemodynamics and oxygenation during isovolemic hemodilution in anesthetized pigs. Adv Exp Med Biol 317:545-552, 1992.
61. DeFoe GR, Ross CS, Olmstead EM, et al: Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg 71:769-776, 2001.
62. Fang WC, Helm RE, Krieger KH, et al: Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation 96:II-194-199, 1997.
63. Tsai AG, Friesenecker B, McCarthy M, et al: Plasma viscosity regulates capillary perfusion during extreme hemodilution in hamster skinfold model. Am J Physiol 275:H2170-2180, 1998.
64. Funk W, Baldinger V: Microcirculatory perfusion during volume therapy. A comparative study using crystalloid or colloid in awake animals. Anesthesiology 82:975-982, 1995.
65. Laub GW, Dharan M, Riebman JB, et al: The impact of intraoperative autotransfusion on cardiac surgery. A prospective randomized double-blind study. Chest 104:686-689, 1993.
66. Bell K, Stott K, Sinclair CJ, et al: A controlled trial of intraoperative autologous transfusion in cardiothoracic surgery measuring effect on transfusion requirements and clinical outcome. Transfus Med 2:295-300, 1992.
67. Martin J, Robitaille D, Perrault LP, et al: Reinfusion of mediastinal blood after heart surgery. J Thorac Cardiovasc Surg 120:499-504, 2000.
68. Body SC, Birmingham J, Parks R, et al: Safety and efficacy of shed mediastinal blood transfusion after cardiac surgery: A multicenter observational study. Multicenter Study of Perioperative Ischemia Research Group. J Cardiothorac Vasc Anesth 13:410-416, 1999.
69. Walpoth BH, Eggensperger N, Hauser SP, et al: Effects of unprocessed and processed cardiopulmonary bypass blood retransfused into patients after cardiac surgery. Int J Artif Organs 22:210-216, 1999.
70. de Haan J, Boonstra PW, Monnink SH, et al: Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis. Ann Thorac Surg 59:901-907, 1995.
71. Bland LA, Villarino ME, Arduino MJ, et al: Bacteriologic and endotoxin analysis of salvaged blood used in autologous transfusions during cardiac operations. J Thorac Cardiovasc Surg 103:582-588, 1992.
72. Schonberger JP, van Oeveren W, Bredee JJ, et al: Systemic blood activation during and after autotransfusion. Ann Thorac Surg 57:1256-1262, 1994.
73. Dalrymple-Hay MJ, Pack L, Deakin CD, et al: Autotransfusion of washed shed mediastinal fluid decreases the requirement for autologous blood transfusion following cardiac surgery: A prospective randomized trial. Eur J Cardiothorac Surg 15:830-834, 1999.
74. Dietrich W, Spannagl M, Jochum M, et al: Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. Anesthesiology 73:1119-1126, 1990.
75. Brown RS, Thwaites BK, Mongan PD: Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: A double- blind, randomized, placebo-controlled trial. Anesth Analg 85:963-970, 1997.
76. Hardy JF, Belisle S, Dupont C, et al: Prophylactic tranexamic acid and epsilon-aminocaproic acid for primary myocardial revascularization. Ann Thorac Surg 65:371-366, 1998.
77. Van der Linden P, De Hert S, Daper A, et al: A standardized multidisciplinary approach reduces the use of allogeneic blood products in patients undergoing cardiac surgery. Can J Anaesth 48:894-901, 2001.
78. Murkin JM, Haig GM, Beer KJ, et al: Aprotinin decreases exposure to allogeneic blood during primary unilateral total hip replacement. J Bone Joint Surg Am 82:675-684, 2000.
79. Munoz JJ, Birkmeyer NJ, Birkmeyer JD, et al: Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery? A meta-analysis. Circulation 99:81-89, 1999.
80. Laupacis A, Fergusson D: Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Anesth Analg 85:1258-1267, 1997.
81. Wong BI, McLean RF, Fremes SE, et al: Aprotinin and tranexamic acid for high transfusion risk cardiac surgery. Ann Thorac Surg 69:808-816, 2000.
82. Bennett-Guerrero E, Sorohan JG, Gurevich ML, et al: Cost-benefit and efficacy of aprotinin compared with epsilon-aminocaproic acid in patients having repeated cardiac operations: A randomized, blinded clinical trial. Anesthesiology 87:1373-1380, 1997.
83. Rich JB: The efficacy and safety of aprotinin use in cardiac surgery. Ann Thorac Surg 66:S6-11; discussion S25-28, 1998.
84. Havel M, Grabenwoger F, Schneider J, et al: Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood. J Thorac Cardiovasc Surg 107:807-810, 1994.
85. Lemmer JH, Jr, Stanford W, Bonney SL, et al: Aprotinin for coronary bypass operations: Efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study. J Thorac Cardiovasc Surg 107:543-551; discussion 551-553, 1994.
86. Rydin E, Lundberg PO: Letter: Tranexamic acid and intracranial thrombosis. Lancet 2:49, 1976.
87. Slaughter TF, Faghih F, Greenberg CS, et al: The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery. Anesth Analg 85:1221-1226, 1997.
88. Royston D, von Kier S: Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 86:575-578, 2001.
89. Nuttall GA, Oliver WC, Santrach PJ, et al: Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 94:773-781; discussion 5A-6A, 2001.
90. Shore-Lesserson L, Manspeizer HE, DePerio M, et al: Thromboelastography- guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 88:312-319, 1999.
91. Spiess BD, Gillies BS, Chandler W, et al: Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth 9:168-173, 1995.
92. Dorman BH, Spinale FG, Bailey MK, et al: Identification of patients at risk for excessive blood loss during coronary artery bypass surgery: Thromboelastography versus coagulation screen. Anesth Analg 76:694-700, 1993.
93. Ti LK, Cheong KF, Chen FG: Prediction of excessive bleeding after coronary artery bypass graft surgery: The influence of timing and heparinase on thromboelastography. J Cardiothorac Vasc Anesth 16:545-550, 2002.
94. Spiess BD, Tuman KJ, McCarthy RJ, et al: Thromboelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clin Monit 3:25-30, 1987.
95. Shih RL, Cherng YG, Chao A, et al: Prediction of bleeding diathesis in patients undergoing cardiopulmonary bypass during cardiac surgery: Viscoelastic measures versus routine coagulation test. Acta Anaesthesiol Sin 35:133-139, 1997.
96. Wang JS, Lin CY, Hung WT, et al: Thromboelastogram fails to predict postoperative hemorrhage in cardiac patients [see comments]. Ann Thorac Surg 53:435-439, 1992.
97. Nuttall GA, Oliver WC, Ereth MH, et al: Coagulation tests predict bleeding after cardiopulmonary bypass [see comments]. J Cardiothorac Vasc Anesth 11:815-823, 1997.
98. Cammerer U, Dietrich W, Rampf T, et al: The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 96:51-57, table of contents, 2003.
99. Koster A, Fischer T, Praus M, et al: Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management. Anesthesiology 97:837-841, 2002.
100. Shore-Lesserson L, Reich DL, DePerio M: Heparin and protamine titration do not improve haemostasis in cardiac surgical patients. Can J Anaesth 45:10-18, 1998.
101. Despotis GJ, Joist JH, Hogue CW Jr, et al: More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT. Thromb Haemost 76:902-908, 1996.
102. Jobes DR, Aitken GL, Shaffer GW: Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. J Thorac Cardiovasc Surg 110:36-45, 1995.
103. Faught C, Wells P, Fergusson D, et al: Adverse effects of methods for minimizing perioperative allogeneic transfusion: A critical review of the literature. Transfus Med Rev 12:206-225, 1998.
104. Rosengart TK, Helm RE, DeBois WJ, et al: Open heart operations without transfusion using a multimodality blood conservation strategy in 50 Jehovah's Witness patients: implications for a "bloodless" surgical technique. J Am Coll Surg 184:618-629, 1997.
105. Ovrum E, Holen EA, Abdelnoor M, et al: Conventional blood conservation techniques in 500 consecutive coronary artery bypass operations. Ann Thorac Surg 52:500-505, 1991.
106. LoCicero J 3rd, Massad M, Gandy K, et al: Aggressive blood conservation in coronary artery surgery: impact on patient care. J Cardiovasc Surg (Torino) 31:559-563, 1990.
107. Goodnough LT, Despotis GJ, Hogue CW Jr, et al: On the need for improved transfusion indicators in cardiac surgery. Ann Thorac Surg 60:473-480, 1995.